Drug recall · July 9, 2014
Bystolic recall
Why: Failed Dissolution Specifications: Drug failed stage III dissolution testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
- Lots / codes
Lot # A308879, Expiry: 09/2015
- Quantity
- 92,544 Bottles
- Company
- Forest Pharmaceuticals Inc, Earth City, MO
- Distribution
- Nationwide including Puerto Rico.
- Initiated
- June 19, 2014 · Voluntary: Firm initiated
- Classified
- June 30, 2014
- Reported
- July 9, 2014
- Ended
- January 5, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bystolic
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.